Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Helicase-inactivating mutations as a basis for dominant negative phenotypes Wu Y; Brosh RM JrCell Cycle 2010[Oct]; 9 (20): 4080-90There is ample evidence from studies of both unicellular and multicellular organisms that helicase-inactivating mutations lead to cellular dysfunction and disease phenotypes. In this review, we will discuss the mechanisms underlying the basis for abnormal phenotypes linked to mutations in genes encoding DNA helicases. Recent evidence demonstrates that a clinically relevant patient missense mutation in Fanconi Anemia Complementation Group J exerts detrimental effects on the biochemical activities of the FANCJ helicase, and these molecular defects are responsible for aberrant genomic stability and a poor DNA damage response. The ability of FANCJ to use the energy from ATP hydrolysis to produce the force required to unwind duplex or G-quadruplex DNA structures or destabilize protein bound to DNA is required for its DNA repair functions in vivo. Strikingly, helicase-inactivating mutations can exert a spectrum of dominant negative phenotypes, indicating that expression of the mutant helicase protein potentially interferes with normal DNA metabolism and has an effect on basic cellular processes such as DNA replication, the DNA damage response and protein trafficking. This review emphasizes that future studies of clinically relevant mutations in helicase genes will be important to understand the molecular pathologies of the associated diseases and their impact on heterozygote carriers.|*DNA Repair[MESH]|*DNA Replication[MESH]|*Phenotype[MESH]|Amino Acid Sequence[MESH]|Animals[MESH]|Apoptosis/genetics[MESH]|Bacterial Proteins/genetics/metabolism[MESH]|DNA Damage[MESH]|DNA Helicases/*antagonists & inhibitors/*genetics/metabolism[MESH]|Fanconi Anemia/enzymology/genetics[MESH]|Fungal Proteins/genetics/metabolism[MESH]|Genetic Complementation Test[MESH]|Humans[MESH]|Molecular Sequence Data[MESH]|Mutation[MESH]|Tumor Suppressor Protein p53/metabolism[MESH] |
